COPD Exacerbations and Increased Cardiovascular Risk

Published Online: Friday, January 17, 2014
Follow Pharmacy_Times:
In this podcast, Nitin Seam, MD, assistant professor of medicine at George Washington University, talks with Anant Patel, MBBS, MRC clinical research fellow at the Center for Respiratory Medicine, University College London, and Mark Dransfield, MD, associate professor of medicine at UAB School of Medicine and medical director of the UAB Lung Health Center, about a new study of the link between acute exacerbations of COPD and cardiovascular risk.

To listen to this podcast, click here.
Related Articles
Live medication therapy management (MTM) reduces low-density-lipoprotein cholesterol significantly more than standard, chart-review MTM.
The results of an FDA safety review of omalizumab (Xolair) suggest the asthma drug slightly elevates the risk of serious cardiovascular and cerebrovascular adverse events.
Combining 2 classes of COPD medications leads to better outcomes for older adults with comorbid asthma.
New late-stage trial data show ivabradine reduces cardiovascular death or hospitalization for worsening chronic heart failure in patients with low systolic blood pressure.
Latest Issues
$auto_registration$